(Q39146620)

English

Relationship between thiolactonase activity and hyperhomocysteinemia according to MTHFR gene polymorphism in Tunisian Behçet's disease patients

scientific article published on January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 September 2017

Relationship between thiolactonase activity and hyperhomocysteinemia according to MTHFR gene polymorphism in Tunisian Behçet's disease patients (English)

1 reference

Europe PubMed Central

9 September 2017

Behçet's disease

0 references

author name string

Nadia Koubaa

1

1 reference

Europe PubMed Central

9 September 2017

Sonia Hammami

2

1 reference

Europe PubMed Central

9 September 2017

Amel Nakbi

3

1 reference

Europe PubMed Central

9 September 2017

Khaldoun Ben Hamda

4

1 reference

Europe PubMed Central

9 September 2017

Sylvia Mahjoub

5

1 reference

Europe PubMed Central

9 September 2017

Testsuya Kosaka

6

1 reference

Europe PubMed Central

9 September 2017

Mohamed Hammami

7

1 reference

Europe PubMed Central

9 September 2017

publication date

1 January 2008

1 reference

Europe PubMed Central

9 September 2017

Clinical Chemistry and Laboratory Medicine

1 reference

Europe PubMed Central

9 September 2017

46

1 reference

Europe PubMed Central

9 September 2017

2

1 reference

Europe PubMed Central

9 September 2017

187-192

1 reference

Europe PubMed Central

9 September 2017

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.046

21 January 2018

Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine level in Behçet's disease

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.046

21 January 2018

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.046

21 January 2018

Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.046

21 January 2018

Investigation of the relationship between atherosclerosis and paraoxonase or homocysteine thiolactonase activity in patients with type 2 diabetes mellitus using a commercially available assay

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.046

21 January 2018

A simple salting out procedure for extracting DNA from human nucleated cells

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.046

21 January 2018

5,10-Methylenetetrahydrofolate reductase C677T gene polymorphism in Behcet's patients with or without ocular involvement.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.046

21 January 2018

Hyperhomocysteinaemia in Behçet's disease.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.046

21 January 2018

Homocysteine: an activity marker in Behçet's disease?

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.046

21 January 2018

Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.046

21 January 2018

The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dy

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.046

21 January 2018

Serum paraoxonase activity is decreased in the active stage of Behçet's disease

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.046

21 January 2018

Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.046

21 January 2018

Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.046

21 January 2018

Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.046

21 January 2018

Hyperhomocysteinemia and Atherosclerotic Vascular Disease

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.046

21 January 2018

Identifiers

10.1515/CCLM.2008.046

1 reference

Europe PubMed Central

9 September 2017

release_italbgbu7fgktolvgdupvirmgi

1 reference

https://api.fatcat.wiki/v0/release/italbgbu7fgktolvgdupvirmgi

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39146620&oldid=1837640628"